CGABL: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income	599,200	486,700
Depreciation and amortization	143,100	94,600
Equity-based compensation	287,100	196,400
Non-cash performance allocations and incentive fees, net	-13,100	250,600
Non-cash principal investment income	50,200	-32,600
Other non-cash amounts	-35,900	-36,800
Realized/unrealized (gain) loss on investments of consolidated funds	100,100	11,600
Realized/unrealized (gain) loss from loans payable of consolidated funds	76,000	41,300
Purchases of investments by consolidated funds	8,990,300	4,033,200
Proceeds from sales and settlements of investments by consolidated funds	5,169,300	2,311,100
Non-cash interest income, net	13,000	8,700
Change in cash and cash equivalents held at consolidated funds	-317,100	-405,400
Change in other receivables held at consolidated funds	8,000	-10,500
Change in other liabilities held at consolidated funds	65,300	-14,000
Purchases of investments	251,100	144,300
Proceeds from the sale of investments	664,000	469,600
Payments of contingent consideration	2,700	1,000
Changes in deferred taxes, net	67,500	16,500
Change in due from affiliates and other receivables	8,700	16,300
Change in deposits and other	25,400	24,900
Change in accounts payable, accrued expenses and other liabilities	37,800	39,100
Change in accrued compensation and benefits	-61,400	-116,200
Change in due to affiliates	25,100	23,600
Change in lease right-of-use assets and lease liabilities	-9,700	-6,300
Change in deferred revenue	226,700	57,600
Net cash used in operating activities	-2,080,400	-520,900
Purchases of corporate treasury investments	0	0
Proceeds from corporate treasury investments	0	-
Purchases of fixed assets, net	57,400	34,200
Net cash used in investing activities	-57,400	-34,200
Borrowings under credit facilities	0	0
Repayments under credit facilities	0	0
Issuance of 5.05 senior notes due 2035, net of financing costs	792,900	-
Payments on clo borrowings	52,000	40,100
Proceeds from clo borrowings, net of financing costs	64,800	15,100
Net borrowings on loans payable of consolidated funds	2,755,100	1,055,100
Dividends to common stockholders	379,200	252,700
Payment of deferred consideration for carlyle holdings units	0	0
Contributions from non-controlling interest holders	599,100	231,300
Distributions to non-controlling interest holders	308,100	198,400
Common shares repurchased and net share settlement of equity-based awards	482,800	280,100
Change in due to/from affiliates financing activities	-25,600	3,400
Net cash provided by financing activities	3,015,400	526,800
Effect of foreign exchange rate changes	82,300	38,700
Increase (decrease) in cash, cash equivalents and restricted cash	959,900	10,400
Cash and cash equivalents at beginning of period	1,266,500	-
Cash and cash equivalents at end of period	2,226,400	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

CGABL: the cashflow